Skip to content

News

Next-Generation Wound Dressing Microlyte Matrix Heals a Majority of Chronic Wounds in a First Published Prospective Clinical Study

MADISON, WI, NOVEMBER 13, 2020 (BUSINESS WIRE) Imbed Biosciences, Inc. (Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a first prospective clinical evaluation of its next-generation wound dressing, Microlyte® Matrix, in complex chronic wounds.… Read More »Next-Generation Wound Dressing Microlyte Matrix Heals a Majority of Chronic Wounds in a First Published Prospective Clinical Study

Imbed Biosciences Reveals New Brand Identity for Company and Flagship Product Microlyte® Matrix for Wound Care

MADISON, WI, DECEMBER 6, 2019 (via BUSINESS WIRE) Imbed Biosciences Inc. (Imbed), a privately-held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers, and surgical wounds, announced today the launch of its new corporate and product brand identities,… Read More »Imbed Biosciences Reveals New Brand Identity for Company and Flagship Product Microlyte® Matrix for Wound Care

Patient Resources

The body is a complex and remarkable machine, and the dynamic process of wound healing is a great example of how our body’s different systems, along with the proper wound care products, work together to repair and replace devitalized tissues. But how, exactly, does our… Read More »Patient Resources

Imbed Biosciences Extends Series A Financing to $4 Million to Commercialize Innovative Bioresorbable Bandage

MADISON, WI, NOVEMBER 5, 2019 Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, announced today that it has closed its Series A Preferred Stock equity financing, which… Read More »Imbed Biosciences Extends Series A Financing to $4 Million to Commercialize Innovative Bioresorbable Bandage

Microlyte Matrix Featured in Clinical Research Presented at National Wound Healing Conference

MADISON, WI, OCTOBER 12, 2019 Imbed Biosciences, a developer of advanced biomaterials and soft tissue repair devices, announced today that clinical results documenting the use of its flagship product, Microlyte® Matrix resorbable antimicrobial wound matrix, will be presented at the Fall Symposium on Advanced Wound… Read More »Microlyte Matrix Featured in Clinical Research Presented at National Wound Healing Conference

MicroLyte® Ag Matrix Clinical Performance to be Featured at National Wound Healing Conference

Madison, WI, April 22, 2019– Imbed Biosciences, a developer of advanced biomaterials and soft tissue repair devices, announced today that clinical results documenting the use of its flagship product, MicroLyte® Ag resorbable antimicrobial wound matrix, will be presented at the Spring Symposium on Advanced Wound Care (SAWC) in San… Read More »MicroLyte® Ag Matrix Clinical Performance to be Featured at National Wound Healing Conference

Imbed Biosciences Closes $2 Million in Series A Financing to Commercialize Wound Healing Matrix

MADISON, WI, APRIL 18, 2018 Imbed Biosciences, Inc. (Imbed), a medical device company emerging as a leader in the development of advanced therapies for soft tissue repair, announced today that it has secured $2 million in a Series A Preferred Stock equity financing. The funding… Read More »Imbed Biosciences Closes $2 Million in Series A Financing to Commercialize Wound Healing Matrix